3.14
+0.04(+1.29%)
Currency In USD
| Previous Close | 3.1 |
| Open | 3.17 |
| Day High | 3.17 |
| Day Low | 3.02 |
| 52-Week High | 13.88 |
| 52-Week Low | 2.7 |
| Volume | 6.66M |
| Average Volume | 10.1M |
| Market Cap | 1.05B |
| PE | -2.45 |
| EPS | -1.28 |
| Moving Average 50 Days | 3.58 |
| Moving Average 200 Days | 7.43 |
| Change | 0.04 |
If you invested $1000 in Iovance Biotherapeutics, Inc. (IOVA) 10 years ago, it would be worth $267.7 as of May 07, 2025 at a share price of $3.1. Whereas If you bought $1000 worth of Iovance Biotherapeutics, Inc. (IOVA) shares 5 years ago, it would be worth $91.77 as of May 07, 2025 at a share price of $3.1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
GlobeNewswire Inc.
May 02, 2025 8:01 PM GMT
SAN CARLOS, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
GlobeNewswire Inc.
Apr 23, 2025 8:15 PM GMT
SAN CARLOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patien
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
GlobeNewswire Inc.
Feb 18, 2025 9:01 PM GMT
SAN CARLOS, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patient